As August 5 approaches, Amgen (AMGN) gears up to reveal its Q2 2025 earnings after market close, and expectations are high ...

On July 15, 2025, Biocon Biologics, a fully integrated global biosimilars company and a subsidiary of Biocon Ltd., announced that the FDA has ...

ALVO preps for Q2 results as investors eye early U.S. traction for Simlandi and Selarsdi, plus pipeline progress.

We expect Amgen AMGN to beat expectations when it reports second-quarter 2025 results on Aug. 5 after market close. In the last reported quarter, the company beat earnings expectations by 17.8%. The ...

Five Dogs of the Dow stocks offer big yields, a degree of safety from tariffs, and a long history of corporate success.

On July 16, 2025, the District Court for the District of New Jersey entered a Consent Judgment and Injunction in view of a settlement ...

Dr. Reddy's Laboratories Limited RDY reported first-quarter fiscal 2026 earnings of 20 cents per American Depositary Share ...

Every ~20 seconds in the U.S a woman aged 50 or older suffers a fracture.1 These fractures result in higher rates of hospitalization than heart attack, stroke, or breast cancer, while having ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Amgen Inc. (AMGN) is a California-based biopharmaceutical company focused on developing and delivering human therapeutics, especially in oncology, inflammation, bone health, and rare diseases. With a ...

Amgen combines patent protection, a robust pipeline, and strong execution for defensive investment. Click here to read an analysis of AMGN stock now.